Home Cart Sign in  
Chemical Structure| 4936-47-4 Chemical Structure| 4936-47-4

Structure of Nifuratel
CAS No.: 4936-47-4

Chemical Structure| 4936-47-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Nifuratel is a broad-spectrum antibacterial used in the treatment of a wide range of infections of the genitourinary tract.

Synonyms: NF 113; SAP 113; Tydantil

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Nifuratel

CAS No. :4936-47-4
Formula : C10H11N3O5S
M.W : 285.28
SMILES Code : O=C1OC(CSC)CN1/N=C/C2=CC=C([N+]([O-])=O)O2
Synonyms :
NF 113; SAP 113; Tydantil
MDL No. :MFCD00057257

Safety of Nifuratel

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Hela 100 µM 20 hours To evaluate the antibacterial effect of Nifuratel in human epithelial cells Hela, results showed that 100 µM of Nifuratel completely killed Salmonella. Microbiol Spectr. 2023 Sep 21;11(5):e0514722
HD11 100 µM 20 hours To evaluate the antibacterial effect of Nifuratel in avian macrophages HD11, results showed that 100 µM of Nifuratel completely killed Salmonella. Microbiol Spectr. 2023 Sep 21;11(5):e0514722
J774A.1 50 µM 20 hours To evaluate the antibacterial effect of Nifuratel in different cell lines, results showed that in J774A.1 cells, 50 µM of Nifuratel completely killed Salmonella. Microbiol Spectr. 2023 Sep 21;11(5):e0514722
RAW264.7 25 µM 20 hours To evaluate the antibacterial effect of Nifuratel on intracellular Salmonella, results showed that at 25 µM, Nifuratel significantly reduced the number of Salmonella. Microbiol Spectr. 2023 Sep 21;11(5):e0514722
Atopobium vaginae 0.125 to 1 μg/ml (MIC) 3 days To evaluate the antimicrobial activity of nifuratel against Atopobium vaginae, results showed high activity against A. vaginae. Antimicrob Agents Chemother. 2011 May;55(5):2490-2
Gardnerella vaginalis 0.125 to 4 μg/ml (MIC) 3 days To evaluate the antimicrobial activity of nifuratel against Gardnerella vaginalis, results showed high activity against G. vaginalis. Antimicrob Agents Chemother. 2011 May;55(5):2490-2
BMMCs 0.94 µM (IC50) 30 minutes To evaluate the inhibitory effect of Nifuratel on IgE-mediated mast cell degranulation. Results showed that Nifuratel reversibly inhibited antigen-induced mast cell degranulation. Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231202349
RBL-2H3 cells 0.34 µM (IC50) 30 minutes To evaluate the inhibitory effect of Nifuratel on IgE-mediated mast cell degranulation. Results showed that Nifuratel reversibly inhibited antigen-induced mast cell degranulation. Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231202349
BGC-823 cells 133.7 µM 48 hours To evaluate the effect of Nifuratel on gastric cancer cell proliferation, results showed that Nifuratel significantly inhibited the proliferation of BGC-823 cells. Cancer Manag Res. 2017 Nov 1;9:565-572
SGC-7901 cells 169.7 µM 48 hours To evaluate the effect of Nifuratel on gastric cancer cell proliferation, results showed that Nifuratel significantly inhibited the proliferation of SGC-7901 cells. Cancer Manag Res. 2017 Nov 1;9:565-572
MDA-MB-453 30.18±0.71 µM (IC50) 72 hours Evaluate the inhibitory effect of NF113 on cell proliferation Pharmaceuticals (Basel). 2024 Sep 26;17(10):1269
BT-549 23.71 ±0.32 µM (IC50) 72 hours Evaluate the inhibitory effect of NF113 on cell proliferation Pharmaceuticals (Basel). 2024 Sep 26;17(10):1269
HCC-1806 29.58 ±0.84 µM (IC50) 72 hours Evaluate the inhibitory effect of NF113 on cell proliferation Pharmaceuticals (Basel). 2024 Sep 26;17(10):1269
MDA-MB-468 19.55 ±0.15 µM (IC50) 72 hours Evaluate the inhibitory effect of NF113 on cell proliferation Pharmaceuticals (Basel). 2024 Sep 26;17(10):1269
MDA-MB-231 20.0 ±0.2 µM (IC50) 72 hours Evaluate the inhibitory effect of NF113 on cell proliferation Pharmaceuticals (Basel). 2024 Sep 26;17(10):1269

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Balb/c mice Passive cutaneous anaphylaxis (PCA) model Oral 10, 30, or 100 mg/kg Single dose To evaluate the inhibitory effect of Nifuratel on IgE-mediated passive cutaneous anaphylaxis. Results showed that Nifuratel dose-dependently suppressed PCA reaction (ED50 approximately 22 mg/kg). Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231202349
BALB/c mice Salmonella infection model Oral 20 mg/kg Every 48 hours for 10 days To evaluate the protective effect of Nifuratel in a mouse Salmonella infection model, results showed that Nifuratel significantly reduced bacterial numbers in the liver and spleen and improved the survival rate of mice. Microbiol Spectr. 2023 Sep 21;11(5):e0514722
Balb/c nude mice MDA-MB-468 cell-derived xenograft model Gavage 400 mg/kg Every 2 days for 27 days Evaluate the anti-tumor effect of NF113 in vivo Pharmaceuticals (Basel). 2024 Sep 26;17(10):1269

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.51mL

0.70mL

0.35mL

17.53mL

3.51mL

1.75mL

35.05mL

7.01mL

3.51mL

References

 

Historical Records

Categories